Orchid Pharma Board Meeting on Aug 1 to Approve Dhanuka Merger Share Allotment

Orchid Pharma Ltd has scheduled a Board of Directors meeting for August 1, 2026, to consider and approve the allotment of fully paid-up equity shares. This allotment is part of the amalgamation scheme where Dhanuka Laboratories Limited will merge with Orchid Pharma Limited. Eligible shareholders of Dhanuka Laboratories as of the record date, July 23, 2026, will receive these shares. This meeting follows a prior intimation dated July 10, 2026, and complies with SEBI's listing regulations.